Valneva SE is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001. VLA2001 is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe. Bouygues Energies & Services has been selected for the turnkey design and build of their manufacturing facility, located in Livingston, Scotland. Source: Cleanroom Technology 18/1/21